RECRUITING

Using Technology to Track Pain and Pain-related Outcomes

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Persistent pain is a public health epidemic. The current protocol seeks to develop technology to aid patients' tracking of patients' pain, medications and pain-related variables. The investigators seek to talk with patients in co-investigator's clinic to solicit feedback, as well as pilot test the technology with pain patients.

Official Title

Using Technology to Track Pain and Pain-related Outcomes

Quick Facts

Study Start:2020-08-10
Study Completion:2025-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04267588

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * ≥ 21 years of age
  2. * Pain duration \> 3 months
  3. * Average pain level of \>3 out of 10 (0=no pain; 10=worst pain imaginable)
  4. * English fluency
  5. * Are not scheduled to undergo any medical procedures during the course of the study
  6. * Have a physician-confirmed medical diagnosis associated with chronic pain
  7. * Are willing to comply with the study protocol and give written informed consent. Patients taking non-narcotic analgesics must be on a stable dose one month prior to participation.
  1. * Delirium, dementia, or cognitive impairment (i.e., Mini Mental State Exam score \<24)
  2. * Unstable major psychiatric disorder or history of schizophrenia
  3. * Beck Depression Inventory score \>30 or report of suicidal ideation
  4. * Active substance abuse;
  5. * Refusal to provide access to relevant medical record information.

Contacts and Locations

Study Contact

Luis F Buenaver, PhD
CONTACT
410-550-7000
lbuenav1@jhmi.edu
Luis F Buenaver, Ph. D
CONTACT
410-550-7986
lbuenav1@jhmi.edu

Principal Investigator

Luis F Buenaver, Ph. D
PRINCIPAL_INVESTIGATOR
Johns Hopkins University

Study Locations (Sites)

Behavioral Medicine Research Lab
Baltimore, Maryland, 21224
United States

Collaborators and Investigators

Sponsor: Johns Hopkins University

  • Luis F Buenaver, Ph. D, PRINCIPAL_INVESTIGATOR, Johns Hopkins University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-08-10
Study Completion Date2025-06-30

Study Record Updates

Study Start Date2020-08-10
Study Completion Date2025-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Pain, Chronic